Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet Among Celiacs [GluCED]
GluCED
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
The study assessed whether compete healing of duodenal mucosa in celiac patients with persistent Marsh I-II lesion after 1 year of gluten free diet (GFD):
- could be achieved by adoption of a diet based exclusively on naturally gluten free products, with the elimination of commercially available processed food (GCED, Gluten Contamination Elimination Diet);
- may depend upon time of exposure to GFD. Investigators studied two cohorts of celiac patients, both on GFD, for at least one year:
- cohort A: patients re-biopsied after three months on GCED;
- cohort B: patients re-biopsied after a minimum of further two years on standard GFD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 7, 2016
CompletedFirst Posted
Study publicly available on registry
March 17, 2016
CompletedOctober 27, 2016
October 1, 2016
1.3 years
March 7, 2016
October 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Histologic classification
Assessment of Marsh class (0-I-II-III) on duodenal biopsies in participants from both cohorts
three months in cohort A, at least sixty months in cohort B
Secondary Outcomes (3)
Celiac disease serology
three months in cohort A, at least sixty months in cohort B
TCR+ T cells count
three months in cohort A, sixty months in cohort B
Eosinophils count
three months in cohort A, sixty months in cohort B
Study Arms (2)
A, GCED cohort
ACTIVE COMPARATORGCED, Gluten Contamination Elimination Diet
B, time cohort
NO INTERVENTIONCohort B consisted of patients on long term follow-up that accepted a repeated biopsies 60 or more months later the first control biopsy.
Interventions
A Gluten Free diet based exclusively on naturally gluten-free products and foods, with the elimination from the diet of all commercially available processed food and products labeled "gluten free " (Gluten Contamination Elimination Diet, GCED).
Eligibility Criteria
You may qualify if:
- Marsh I-II lesion at 12-18 months after starting GFD
- Negative Celiac Disease serology
- Strict adherence to gluten free diet without digression
You may not qualify if:
- presence of Gastrointestinal Symtoms
- presence of Helicobacter pylori infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
barbara zanini, MD, PhD
Università degli Studi di Brescia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Gastroenterology, PhD
Study Record Dates
First Submitted
March 7, 2016
First Posted
March 17, 2016
Study Start
March 1, 2014
Primary Completion
June 1, 2015
Study Completion
January 1, 2016
Last Updated
October 27, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share